AssetMark Inc’s Standard BioTools LAB Stock Holding History

AssetMark Inc’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-62	Closed	-$137	–	2032
2023 Q4	$137	Buy	+62	New	+$132	﹤0.01%	1803
2016 Q1	–	Sell	-13	Closed	–	–	1305
2015 Q4	$0	Buy	13 +9	+225%	+$88	﹤0.01%	1434
2015 Q3	$0	Buy	+4	New	+$63	﹤0.01%	798

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

AssetMark Inc's LAB Position: Q1 2024 in Review

AssetMark Inc sold out of Standard BioTools (LAB) in Q1 2024, closing a stake of 62 shares — an estimated $137 sold.

AssetMark Inc first reported a position in LAB in Q3 2015 and held it in 3 quarters. The position peaked at $137 in Q4 2023. 145 funds tracked by Wall St. Rank hold LAB as of Q1 2024.

AssetMark Inc reported no remaining Standard BioTools position as of Q1 2024 after selling out during the quarter.
AssetMark Inc sold 62 Standard BioTools shares in Q1 2024, an estimated $137.
AssetMark Inc first reported a position in Standard BioTools in Q3 2015 and held it in 3 quarters.
AssetMark Inc's Standard BioTools position peaked at $137 in Q4 2023.
145 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2024.

Based on AssetMark Inc's 13F filing for Q1 2024, filed 7 May 2024.